Earnings Preview For Castle Biosciences
Portfolio Pulse from Benzinga Insights
Castle Biosciences (NASDAQ:CSTL) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $-0.54. Historical data shows the company has previously beaten EPS estimates, leading to significant share price movements. Shares are currently trading at $24.505, up 10.42% over the last year. Investors are keen on both the earnings outcome and the company's future guidance.
February 27, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Castle Biosciences is expected to report an EPS of $-0.54 for the upcoming quarter. Historical performance shows positive stock movement following earnings beats. Shares have risen 10.42% over the past year.
Given Castle Biosciences' history of beating EPS estimates and the subsequent positive stock price reactions, there is a strong likelihood of a positive short-term impact on CSTL's stock price if they beat the EPS estimate again and provide optimistic future guidance. The anticipation of this event, based on past performance, suggests a potential increase in stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100